Galmed Pharmaceuticals Ltd. ( GLMD) - Stock Earnings

GLMD Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -4.8 million USD — USD
2026Q1 -4.8 million USD — USD
2026Q2 -2.7 million USD — USD
2026Q4 Est. — —

GLMD Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -6.9 million USD — USD
2024 -7.5 million USD — USD
2025 -10.3 million USD — USD
2026 Est. — —

GLMD

Price: $4.63

52 week price:
0.41
13.20

Earnings Per Share: -14.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 176487

Ebitda: -2.7 million

Market Capitalization: 4.1 million

Links: